| Keynote: Artios Pharma – targeting DNA repair vulnerabilities in cancer | |||||
|
Wed30 Jun10:10am(50 mins)
|
|
|
Dr Simon Boulton | ||
| Session : Keynote Speaker | |||||
| Room: Conference Room | |||||
| Development of an Intracellular Quantitative Assay to Measure Compound Binding Kinetics | |||||
|
Thu1 Jul09:10am(20 mins)
|
|
|
Charles Lay | ||
| Session : Drugging your target | |||||
| Room: Conference Room | |||||
| Early identification of target candidates for pancreatic adenocarcinoma immunotherapy | |||||
|
Wed30 Jun11:40am(30 mins)
|
|
|
Dr Olaf Hardt |
|
Dr Daniel Schäfer |
| Session : Target ID & Validation | |||||
| Room: Conference Room | |||||
| Hepato-biliary organoids and applications in regenerative medicine | |||||
|
Thu1 Jul01:50pm(25 mins)
|
|
|
Dr Monique Verstegen | ||
| Session : Clinical Insights & Experimental Medicine | |||||
| Room: Conference Room | |||||
| Hit and Run: a rapid route to new target ID with PROTEINi | |||||
|
Wed30 Jun12:10pm(25 mins)
|
|
|
Dr Benedict Cross | ||
| Session : Target ID & Validation | |||||
| Room: Conference Room | |||||
| Identification of novel therapeutics for fibrotic diseases using phenotypic screening | |||||
|
Wed30 Jun02:30pm(20 mins)
|
|
Prof Selim Cellek | |||
| Session : Target ID & Validation | |||||
| Room: Conference Room | |||||
| Leveraging genetic insight into potential drug targets for vascular disease | |||||
|
Thu1 Jul02:30pm(25 mins)
|
|
|
Dr Scott Damrauer | ||
| Session : Clinical Insights & Experimental Medicine | |||||
| Room: Conference Room | |||||
| Perspectives on Consortia & Industry Collaboration | |||||
|
Wed30 Jun04:05pm(10 mins)
|
|
Dr Julie Brady | |||
| Session : Routes to Funding Session | |||||
| Room: Conference Room | |||||
| Perspectives on Grant Funding & Technology Transfer | |||||
|
Wed30 Jun03:45pm(10 mins)
|
|
Dr Paul Mercer | |||
| Session : Routes to Funding Session | |||||
| Room: Conference Room | |||||
| Perspectives on Novel Routes to Translation | |||||
|
Wed30 Jun04:15pm(10 mins)
|
|
Dr Nadine Clemo | |||
| Session : Routes to Funding Session | |||||
| Room: Conference Room | |||||
| Perspectives on Venture Capital | |||||
|
Wed30 Jun03:55pm(10 mins)
|
|
Prof Helen Philippou | |||
| Session : Routes to Funding Session | |||||
| Room: Conference Room | |||||
| Potential use of CRISPR in therapeutic applications | |||||
|
Thu1 Jul10:00am(25 mins)
|
|
Dr Pinar Akcakaya | |||
| Session : Drugging your target | |||||
| Room: Conference Room | |||||
| Routes to Funding Panel Discussion | |||||
|
Wed30 Jun03:40pm(5 mins)
|
|
|
Dr Ian Tomlinson | ||
| Session : Routes to Funding Session | |||||
| Room: Conference Room | |||||
| Session Chair Welcome | |||||
|
Thu1 Jul01:45pm(5 mins)
|
|
Dr Simon Chell |
|
Dr Ajay Gupta | |
| Session : Clinical Insights & Experimental Medicine | |||||
| Room: Conference Room | |||||
| Session Chair Welcome | |||||
|
Wed30 Jun11:10am(5 mins)
|
|
Dr Michael Howell |
|
Dr Sam Groom | |
| Session : Target ID & Validation | |||||
| Room: Conference Room | |||||
| Single-cell CRISPR screens in primary human T cells | |||||
|
Wed30 Jun02:50pm(15 mins)
|
|
|
Dr Tilmann Buerckstuemmer | ||
| Session : Target ID & Validation | |||||
| Room: Conference Room | |||||
| Streamlining Collaboration and Development for Neglected Disease Drug Discovery Using CDD Vault | |||||
|
Wed30 Jun12:35pm(15 mins)
|
|
|
Kelly Bachovchin | ||
| Session : Target ID & Validation | |||||
| Room: Conference Room | |||||
| Targeting KRAS via inhibition of the KRAS-SOS1 interaction | |||||
|
Thu1 Jul11:10am(15 mins)
|
|
|
Dr Roman Hillig | ||
| Session : Drugging your target | |||||
| Room: Conference Room | |||||
| The challenges of a novel target portfolio | |||||
|
Thu1 Jul10:45am(25 mins)
|
|
|
Steve Rees | ||
| Session : Drugging your target | |||||
| Room: Conference Room | |||||
| The consequenses of inaccurate or inappropriate cell analysis for down-stream assays | |||||
|
Thu1 Jul02:15pm(15 mins)
|
|
|
Dr Suzanne Riches | ||
| Session : Clinical Insights & Experimental Medicine | |||||
| Room: Conference Room | |||||
| Keynote: The Many Facets of Prostacyclin Mimetics: Therapeutic Applications in Cardiovascular Disease | |||||
|
Thu1 Jul04:00pm(50 mins)
|
|
|
Prof Lucie Clapp | ||
| Session : Keynote Speaker | |||||
| Room: Conference Room | |||||
| The TRAIL less travelled: targeting the pro-tumourigenic role of TRAIL in cancer | |||||
|
Thu1 Jul03:25pm(25 mins)
|
|
Prof Henning Walczak | |||
| Session : Clinical Insights & Experimental Medicine | |||||
| Room: Conference Room | |||||
| Using Genetics and Genomics to Drive Drug Discovery and Development | |||||
|
Wed30 Jun11:15am(25 mins)
|
|
Victor Neduva | |||
| Session : Target ID & Validation | |||||
| Room: Conference Room | |||||
| Writing and erasing O-GlcNAc from target proteins in cells | |||||
|
Thu1 Jul11:25am(25 mins)
|
|
|
Dr Christina Woo | ||
| Session : Drugging your target | |||||
| Room: Conference Room | |||||
